Ignite Creation Date:
2024-05-06 @ 10:15 AM
Last Modification Date:
2024-10-26 @ 12:27 PM
Study NCT ID:
NCT03207009
Status:
COMPLETED
Last Update Posted:
2024-03-07
First Post:
2017-06-29
Brief Title:
A Study Evaluating the Efficacy and Safety of the LentiGlobin BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia
Sponsor:
bluebird bio
Organization:
bluebird bio
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-08
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-15
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-29
First Submit QC Date:
June 29 2017
Study First Post Date:
2017-07-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-12-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-05
Last Update Post Date:
2024-03-07
Last Update Post Date Type:
ACTUAL